Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial.
Rebecca H HabermanKatrina A MacFarlaneSydney CatronJonathan SamuelsRebecca B BlankMichael ToproverZakwan UddinJiyuan HuRochelle CastilloCinty GongKun QianVincent PiguetFrancisco TauskJensen YeungAndrea L NeimannWayne GulliverRalf G ThieleJoseph F MerolaAlexis OgdieProton RahmanSoumya D ChakravartyLihi EderChristopher T RitchlinJose U ScherPublished in: BMJ open (2022)
NCT05004727.